A novel STAT inhibitor, OPB-31121, has a significant antitumor effect on leukemia with STAT-addictive oncokinases

類似資料

• Phase I Study of OPB-31121, an Oral STAT3 Inhibitor, in Patients with Advanced Solid Tumors
  著者:: Oh, Do-Youn, 等
  出版事項: (2015)
• Hitting the right spot: Mechanism of action of OPB‐31121, a novel and potent inhibitor of the Signal Transducer and Activator of Transcription 3 (STAT3)
  著者:: Brambilla, Lara, 等
  出版事項: (2015)
• The photosensitizer verteporfin has light-independent anti-leukemic activity for Ph-positive acute lymphoblastic leukemia and synergistically works with dasatinib
  著者:: Morishita, Takanobu, 等
  出版事項: (2016)
• Leukemia cell–targeted STAT3 silencing and TLR9 triggering generate systemic antitumor immunity
  著者:: Hossain, Dewan Md Sakib, 等
  出版事項: (2014)
• B Cell Linker Protein (BLNK) Is a Selective Target of Repression by PAX5-PML Protein in the Differentiation Block That Leads to the Development of Acute Lymphoblastic Leukemia
  著者:: Imoto, Naoto, 等
  出版事項: (2016)